Propensity score-matching analysis of local consolidative therapy for patients with oligometastatic non-small cell lung cancer without progression after front-line systemic therapy

被引：0
|
作者：
Zhang, J-T. [1 ]
Liu, S-Y. [1 ]
Lin, J-T. [1 ]
Yan, H-H. [1 ]
Yang, X. N. [1 ]
Wu, Y-L. [1 ]
Zhong, W-Z. [1 ]
机构：
[1] Guangdong Gen Hosp, Dept Pulm, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
444P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Consolidative Local Therapy in oligometastatic NSCLC without Progression after First-line Chemotherapy
    Buergy, Daniel
    Wenz, Frederik
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (04) : 341 - 343
  • [22] Effect of Osimertinib in Non-Small Cell Lung Cancer Patients with Brain Metastases After Progression Following Front-Line EGFR-TKI Therapy
    Yu, X.
    Fan, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S400 - S400
  • [23] Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with first-line pembrolizumab: A retrospective observational study
    Chen, Ya
    Wang, Yanan
    Yang, Zhengyu
    Hu, Minjuan
    Lu, Jun
    Zhang, Yanwei
    Qian, Fangfei
    Zhang, Bo
    Wang, Shuyuan
    Wang, Kai
    Zhang, Wei
    Han, Baohui
    THORACIC CANCER, 2022, 13 (05) : 732 - 741
  • [24] The emerging role of local therapy in oligometastatic non-small cell lung cancer
    Isbell, James M.
    Li, Bob T.
    Gomez, Daniel R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (03): : 819 - 825
  • [25] Local therapy treatment conditions for oligometastatic non-small cell lung cancer
    Zhang, Suli
    Sun, Qian
    Cai, Feng
    Li, Hui
    Zhou, Yufu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer
    Kim, Chul
    Hoang, Chuong D.
    Kesarwala, Aparna H.
    Schrump, David S.
    Guha, Udayan
    Rajan, Arun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 179 - 193
  • [27] Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer
    Billing, David L.
    Rimner, Andreas
    CANCERS, 2021, 13 (22)
  • [28] Pemetrexed plus gemcitabine as front-line therapy for patients with advanced stage non-small cell lung cancer.
    Treat, J
    McCleod, M
    Mintzer, D
    Christiansen, N
    Bonomi, P
    Monberg, M
    Taylor, L
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 648S - 648S
  • [29] Local Consolidative Therapy Versus Systemic Therapy Alone for Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Wu, Yajing
    Verma, Vivek
    Liang, Fei
    Lin, Qiang
    Zhou, Zhiguo
    Wang, Zhiyu
    Wang, Yi
    Wang, Jun
    Chang, Joe Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (04): : 635 - 644
  • [30] Impact of sarcopenia on the prognosis of patients with advanced non-small cell lung cancer treated with antiangiogenic therapy: A propensity score matching analysis
    Huang, Fuchun
    Ma, Mingxuan
    Lang, Liye
    Yang, Shuang
    Zhao, Hui
    Zhang, Jialin
    Liu, Hua
    THORACIC CANCER, 2024, 15 (31) : 2248 - 2259
12345